Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 12.4 Cr.
- Current Price ₹ 3.88
- High / Low ₹ 5.85 / 2.55
- Stock P/E
- Book Value ₹ 15.8
- Dividend Yield 0.00 %
- ROCE -0.10 %
- ROE -0.10 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.25 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 25.9%
- Company has a low return on equity of 10.3% over last 3 years.
- Company has high debtors of 21,097 days.
- Working capital days have increased from 11,249 days to 33,416 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | 39.81 | 0.20 | 1.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| 0.57 | 0.61 | 0.53 | 8.93 | 31.53 | 0.26 | 3.87 | |
| Financing Profit | -0.23 | -0.08 | -0.08 | 0.52 | 8.27 | -0.06 | -2.87 |
| Financing Margin % | -67.65% | -15.09% | -17.78% | 5.50% | 20.77% | -30.00% | -287.00% |
| 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -0.05 | -2.86 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| -0.26 | -0.10 | -0.12 | 0.52 | 8.27 | -0.05 | -2.86 | |
| EPS in Rs | 0.16 | 2.58 | -0.02 | -0.90 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -139% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | -47% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | 12.01 | 32.02 | 32.02 |
| Reserves | -2.60 | -2.69 | -2.81 | -6.05 | 18.56 | 18.51 |
| Borrowing | 3.42 | 3.42 | 3.42 | 10.91 | 0.02 | 0.01 |
| 0.23 | 0.25 | 0.27 | 0.02 | 0.02 | 0.04 | |
| Total Liabilities | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.58 |
| 0.52 | 0.49 | 0.45 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.91 | 2.27 | 2.27 | 0.00 | 0.00 | 0.00 |
| 3.97 | 4.57 | 4.51 | 16.89 | 50.61 | 50.57 | |
| Total Assets | 7.40 | 7.33 | 7.23 | 16.89 | 50.62 | 50.58 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -13.46 | -25.48 | 0.11 | ||||
| 0.00 | -0.01 | 0.00 | ||||
| 12.58 | 25.46 | 0.00 | ||||
| Net Cash Flow | -0.88 | -0.03 | 0.11 | |||
| Free Cash Flow | -13.46 | -25.49 | 0.11 | |||
| CFO/OP | -2,588% | -308% | -183% |
Ratios
Consolidated / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| ROE % | -6.93% | -2.70% | -3.33% | 8.72% | 29.25% | -0.10% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of permanent employees employees ・Standalone data |
|
||||||||
| Number of subsidiaries subsidiaries ・Standalone data |
|||||||||
| Mutual Fund Management revenue share % of total turnover ・Standalone data |
|||||||||
| Stock-in-Trade (securities) - closing quantity shares ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 43rd AGM held on 29 Sep 2026; financials adopted, director reappointed, additional director regularized.
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication for Notice of Annual General meeting
-
Book Closure For Annual General Meetin
- Register and share transfer books closed 22-29 September 2026 for the 43rd AGM.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector